Tuesday, July 23, 2024

NuGen Medical appoints Ian Heynen as CEO

Must read

v

Khaosai Wongnatthakan

  • NuGen Medical (OTCQB:NGMDF) said it has appointed Ian Heynen as the company’s new CEO, effective November 1, 2023, to succeed CEO Richard Buzbuzian.
  • Buzbuzian remains President and a Director of NuGen and will continue to focus on capital markets, corporate finance, and investor relations initiatives.
  • Heynen is a seasoned med-tech company builder with over 20 years of experience leading technology-driven organizations.
  • Most recently, Heynen played a crucial role in Sentinelle Medical’s establishment and expansion, which helped the company attract the attention of Hologic Inc., a large international buyer.

More articles

Latest article